Monday, January 31, 2022

Cell That Might Trigger Alzheimer's Disease

›
  It all started with genetic data. A gene here, a gene there. Eventually the story became clearer: If scientists are to one day find a cure...

Preclinical Alzheimer's: More Common Than We Think?

›
  Prevalence of abnormal amyloid was about 10% higher than previously estimated among people with normal cognition, updated data from the Am...

Should We Prioritize the Development of Omicron-Specific Boosters?

›
  The identification of the   Omicron variant (B.1.1.529)   in South Africa in November 2021 -- featuring an extensive set of 30 mutations i...

COVID Self-Testers May Get Quarantine Wrong With 'Authorized' Instructions

›
  Users of at-home tests for COVID-19 may be less likely to follow CDC quarantine guidelines when using their testing kit instructions than ...

Shionogi Aims to Begin Global Phase 3 Trial of Covid-19 Pill Late-February

›
  Japanese drugmaker Shionogi & Co. said Monday that it plans to start a global Phase 3 trial of its Covid-19 pill as soon as late Febru...

Eagle Pharmaceuticals on Track to Support Submission of NDA for Landiolol

›
  Eagle Pharmaceuticals Inc. said Monday that AOP Orphan Pharmaceuticals GmbH, a member of AOP Health, has begun discussions with the U.S. F...

Elusys Therapeutics Finalizes Contract With U.S. HHS Department

›
  Elusys Therapeutics Inc., which is being bought by Heat Biologics Inc., said it has finalized a contract with the Office of the Assistant ...